Comparison of primary coronary percutaneous coronary intervention between Diabetic Men and Women with acute myocardial infarction
- PMID: 26101503
- PMCID: PMC4476354
- DOI: 10.12669/pjms.312.6646
Comparison of primary coronary percutaneous coronary intervention between Diabetic Men and Women with acute myocardial infarction
Abstract
Objective: This study aimed to explore the short-term efficacy and safety of primary percutaneous coronary intervention (PCI) in female diabetic patients complicated with acute myocardial infarction (AMI).
Methods: A total of 169 diabetic patients with AMI who underwent primary PCI were selected and divided into group A (52 females) and group B (117 males). The clinical data, characteristics of coronary artery lesions, lengths of hospital stay, and incidences of complications were then compared between two groups.
Results: The average age, history of hyperlipidemia, double branch lesions, triple branch lesions, and left main lesions were significantly higher in group A than in group B (P < 0.05). Smoking history, PCI history, and pre-infarction angina were distinctly lower in group A than in group B (P < 0.05). Thrombolysis in myocardial infarction 3 (TIMI3) flow and TIMI myocardial perfusion grade 3 (TMPG3) after PCI were markedly lower in group A than in group B (P < 0.001). Group A had a higher incidence of complications, such as severe arrhythmia, cardiac function Killip III/IV, cardiogenic shock, major, moderate and mild bleed event, as well as a 30-day mortality rate, compared with group B (P < 0.05).
Conclusion: In summary, our study demonstrated that female diabetic patients with AMI had lower TIMI3 flow and TMPG3 following PCI than male patients, while there was higher incidence of complications and 30-day mortality rate. Therefore, more attention should be paid to the therapy of diabetic women with acute myocardial infarction as well as the control of risk factors.
Keywords: Acute myocardial infarction; Diabetes mellitus; Female; primary percutaneous coronary intervention.
Similar articles
-
Effects of Coronary Arterial Injection of Tirofiban on Diabetes Mellitus Complicated with Acute Myocardial Infarction in the Elderly.Acta Cardiol Sin. 2013 Nov;29(6):550-6. Acta Cardiol Sin. 2013. PMID: 27122756 Free PMC article.
-
Efficacy and safety of different doses of tirofiban combined with ticagrelor on diabetic patients with AMI receiving in emergency percutaneous coronary intervention (PCI).Int J Clin Exp Med. 2015 Jul 15;8(7):11360-9. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26379951 Free PMC article.
-
[Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):600-607. doi: 10.3760/cma.j.cn112148-20200327-00254. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32842271 Chinese.
-
Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis.Catheter Cardiovasc Interv. 2019 Jul 1;94(1):70-81. doi: 10.1002/ccd.28062. Epub 2018 Dec 28. Catheter Cardiovasc Interv. 2019. PMID: 30593731
-
Gender differences in the outcome of cardiac interventions.Herz. 2005 Aug;30(5):375-89. doi: 10.1007/s00059-005-2716-3. Herz. 2005. PMID: 16132240 Review. English, German.
Cited by
-
A sex-disaggregated analysis of the prognostic value of lean type 2 diabetes mellitus in the adult population with acute myocardial infarction.Cardiovasc Diabetol. 2025 Feb 7;24(1):59. doi: 10.1186/s12933-024-02552-0. Cardiovasc Diabetol. 2025. PMID: 39920748 Free PMC article.
-
Are women with type 2 diabetes mellitus more susceptible to cardiovascular complications following coronary angioplasty?: a meta-analysis.BMC Cardiovasc Disord. 2017 Jul 27;17(1):207. doi: 10.1186/s12872-017-0645-8. BMC Cardiovasc Disord. 2017. PMID: 28750607 Free PMC article. Review.
-
Protective role of arachidonic acid against diabetic myocardial ischemic injury: a translational study of pigs, rats, and humans.Cardiovasc Diabetol. 2024 Feb 9;23(1):58. doi: 10.1186/s12933-024-02123-3. Cardiovasc Diabetol. 2024. Retraction in: Cardiovasc Diabetol. 2025 Jun 23;24(1):260. doi: 10.1186/s12933-025-02822-5. PMID: 38336692 Free PMC article. Retracted.
-
Therapeutic Effects of Triple Antiplatelet Therapy in Elderly Female Patients with Diabetes and Acute Myocardial Infarction.Arq Bras Cardiol. 2021 Feb;116(2):229-235. doi: 10.36660/abc.20190442. Arq Bras Cardiol. 2021. PMID: 33470329 Free PMC article. Clinical Trial. English, Portuguese.
References
-
- O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Jr, Chung MK, de Lemos JA, et al. ACCF/AHA guideline for the management of ST-elevation myocardial infarction: Executive Summary a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:485–510. doi:10.1016/j.jacc.2012.11.018. - PubMed
-
- West RM, Cattle BA, Bouyssie M, Squire I, de Belder M, Fox KA, et al. Impact of hospital proportion and volume on primary percutaneous coronary intervention performance in England and Wales. Eur Heart J. 2011;32:706–711. doi:10.1093/eurheartj/ehq476. - PubMed
-
- Farhan S, Höchtl T, Kautzky-Willer A, Wojta J, Huber K. Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus. Wien Med Wochenschr. 2010;160:30–38. doi:10.1007/s10354-010-0747-8. - PubMed
-
- Farhan S, Höchtl T, Wojta J, Huber K. Diabetic specific aspects in antithrombotic therapy in patients with coronary artery disease. Minerva Med. 2010;101:239–253. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous